SACHS BRUCE I — SEC insider filings
SEC reporting owner CIK 1197036. 40 insider filings on record with FilingPulse; latest filed 2026-10-19.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2020-10-19 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 3 filings — 35,000 shares, $8,177,531 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 10 legs across 6 filings — 57,368 shares, $21,552,707 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 45.
- Largest priced transaction: sale of 11,250 shares @ $385.00 ($4,331,250) in VERTEX PHARMACEUTICALS INC / MA, filed 2023-11-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | 40 | 6 legs · 35,000 sh · $8,177,531 | 10 legs · 57,368 sh · $21,552,707 | 45 |
Insider filings — SACHS BRUCE I
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 92.69 (derivative) @ $512.44 | EDGAR |
| 2026-08-31 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Gift (G): 6,000 @ $0 | EDGAR |
| 2026-07-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 99.94 (derivative) @ $475.28 | EDGAR |
| 2026-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,866 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 107.34 (derivative) @ $442.50 | EDGAR |
| 2026-01-20 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 107.09 (derivative) @ $443.56 | EDGAR |
| 2025-10-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 115.77 (derivative) @ $410.31 | EDGAR |
| 2025-08-07 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Purchase (P): 1,634 @ $389.36 · Purchase (P): 3,366 @ $389.84 | EDGAR |
| 2025-07-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 101.21 (derivative) @ $469.34 | EDGAR |
| 2025-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,398 (derivative) @ $0 | EDGAR |
| 2025-04-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 95.47 (derivative) @ $497.51 | EDGAR |
| 2025-01-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 111.65 (derivative) @ $420.31 | EDGAR |
| 2024-10-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 90.32 (derivative) @ $484.39 | EDGAR |
| 2024-08-02 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 5,295 @ $125.71 · Sale (S): 5,295 @ $508 · Option exercise (M): 5,295 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 89.26 (derivative) @ $490.12 | EDGAR |
| 2024-05-24 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 7,073 @ $93.51 · Sale (S): 7,073 @ $448 · Option exercise (M): 7,073 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 3,142 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 109.49 (derivative) @ $399.58 | EDGAR |
| 2024-01-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 101.04 (derivative) @ $432.99 | EDGAR |
| 2023-11-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 11,250 @ $127.54 · Sale (S): 11,250 @ $385 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2023-10-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 118.25 (derivative) @ $369.98 | EDGAR |
| 2023-07-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 11,250 @ $127.54 · Sale (S): 1,697 @ $355.54 · Sale (S): 5,711 @ $356.75 · Sale (S): 3,842 @ $357.29 · Grant/award (A): 124.72 (derivative) @ $350.79 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2023-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 3,481 (derivative) @ $0 | EDGAR |
| 2023-04-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 131.47 (derivative) @ $332.77 | EDGAR |
| 2023-04-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 21,300 @ $72.14 · Sale (S): 2,917 @ $325.65 · Sale (S): 10,357 @ $326.46 · Sale (S): 8,026 @ $327.48 · Gift (G): 1,210 @ $0 · Option exercise (M): 21,300 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 1,200 @ $72.14 · Sale (S): 1,200 @ $325.01 · Option exercise (M): 1,200 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 146.61 (derivative) @ $298.42 | EDGAR |
| 2022-10-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 147.40 (derivative) @ $296.82 | EDGAR |
| 2022-07-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 151.26 (derivative) @ $289.23 | EDGAR |
| 2022-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 4,462 (derivative) @ $0 | EDGAR |
| 2022-04-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 151.17 (derivative) @ $289.41 | EDGAR |
| 2022-01-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 189.74 (derivative) @ $230.58 | EDGAR |
| 2021-10-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 240.29 (derivative) @ $182.07 | EDGAR |
| 2021-08-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Purchase (P): 15,000 @ $197.91 | EDGAR |
| 2021-07-16 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 220.96 (derivative) @ $198 | EDGAR |
| 2021-05-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 6,067 (derivative) @ $0 | EDGAR |
| 2021-04-16 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 198.71 (derivative) @ $220.17 | EDGAR |
| 2021-01-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 193.59 (derivative) @ $225.99 | EDGAR |
| 2020-11-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Purchase (P): 6,825 @ $216.47 · Purchase (P): 4,270 @ $217.49 · Purchase (P): 3,905 @ $218.79 | EDGAR |
| 2020-10-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 196.36 (derivative) @ $222.81 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-19 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1197036 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs